Literature DB >> 22735640

Mania associated with infliximab.

Marni Austin1, Yong Chiang Jonathan Tan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22735640     DOI: 10.1177/0004867412450473

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


× No keyword cloud information.
  6 in total

Review 1.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

2.  Inflammation as a Mechanism of Bipolar Disorder Neuroprogression.

Authors:  Tatiana Barichello; Vijayasree Vayalanellore Giridharan; Gursimrat Bhatti; Pavani Sayana; Tejaswini Doifode; Danielle Macedo; Joao Quevedo
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 3.  The immunology of bipolar disorder.

Authors:  Izabela Guimarães Barbosa; Rodrigo Machado-Vieira; Jair C Soares; Antonio L Teixeira
Journal:  Neuroimmunomodulation       Date:  2014-02-14       Impact factor: 2.492

Review 4.  Secondary Mania induced by TNF-α inhibitors: A systematic review.

Authors:  Alessandro Miola; Veronica Dal Porto; Nicola Meda; Giulia Perini; Marco Solmi; Fabio Sambataro
Journal:  Psychiatry Clin Neurosci       Date:  2021-11-02       Impact factor: 12.145

Review 5.  Cytokines in bipolar disorder: paving the way for neuroprogression.

Authors:  Izabela Guimarães Barbosa; Moisés Evandro Bauer; Rodrigo Machado-Vieira; Antonio Lucio Teixeira
Journal:  Neural Plast       Date:  2014-09-09       Impact factor: 3.599

6.  Psychiatric Adverse Events Associated With Infliximab: A Cohort Study From the French Nationwide Discharge Abstract Database.

Authors:  Eve-Marie Thillard; Sophie Gautier; Evgeniya Babykina; Louise Carton; Ali Amad; Guillaume Bouzillé; Jean-Baptiste Beuscart; Grégoire Ficheur; Emmanuel Chazard
Journal:  Front Pharmacol       Date:  2020-04-22       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.